AC
NAUT icon

AXQ Capital’s Nautilus Biotechnolgy NAUT Stock Holding History

AXQ Capital’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
+34,147
New +$90.2K 0.01% 896

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

AXQ Capital's NAUT Position: Q2 2026 in Review

AXQ Capital opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 34,147 shares worth $63.9K. The stake represents 0.01% of the portfolio and ranks #896 among its holdings.

93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • AXQ Capital held 34,147 shares of Nautilus Biotechnolgy worth $63.9K as of Q2 2026.
  • Nautilus Biotechnolgy was a new AXQ Capital position in Q2 2026.
  • Nautilus Biotechnolgy made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #896 holding.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.